Focal hemosiderin deposits and β‐amyloid load in the ADNI cohort

Authors:
  • AIAlzheimer'S Disease Neuroimaging Initiative
    Alzheimer'S Disease Neuroimaging Initiative

Abstract
Background: Prevalence and risk factors for focal hemosiderin deposits are important considerations when planning amyloid‐modifying trials for treatment and prevention of Alzheimer's disease (AD).Methods: Subjects were cognitively normal (n = 171), early‐mild cognitive impairment (MCI) (n = 240), late‐MCI (n = 111), and AD (n = 40) from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Microhemorrhages and superficial siderosis were assessed at baseline and on all available MRIs at 3, 6, and 12 months. β‐amyloid load was assessed with 18F‐florbetapir positron emission tomography.Results: Prevalence of superficial siderosis was 1% and prevalence of microhemorrhages was 25% increasing with age (P < .001) and β‐amyloid load (P < .001). Topographic densities of microhemorrhages were highest in the occipital lobes and lowest in the deep/infratentorial regions. A greater number of microhemorrhages at baseline was associated with a greater annualized rate of additional microhemorrhages by last follow‐up (rank correlation = 0.49; P < .001).Conclusions: Focal hemosiderin deposits are relatively common in the ADNI cohort and are associated with β‐amyloid load.
Funding Information
  • Alzheimer's Disease Neuroimaging Initiative
  • National Institutes of Health (U01 AG024904)

This publication has 34 references indexed in Scilit: